Emergent Biosolutions Q3 2021 Financial Performance Analysis

Wednesday, 6 March 2024, 21:50

Emergent Biosolutions released its financial results for the third quarter of 2021, with a Non-GAAP EPS of -$0.77 missing expectations by $0.45. However, the company's revenue of $276.6M beat estimates by $2.6M. The report reflects a mixed performance for Emergent Biosolutions in the current quarter, with challenges in earnings per share offset by better-than-expected revenue figures.
LivaRava Finance Meta Image
Emergent Biosolutions Q3 2021 Financial Performance Analysis

Emergent Biosolutions Q3 2021 Financial Results Analysis

Emergent Biosolutions announced its financial results for the third quarter of 2021, revealing a Non-GAAP EPS of -$0.77, missing expectations by $0.45. However, the company's revenue stood at $276.6M, exceeding estimates by $2.6M. The quarterly report indicates a mixed performance for Emergent Biosolutions.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe